Are you suffering from Hidradenitis Suppurativa (or HS)?
If you are suffering from HS, we are seeking volunteers for participation in one of the following HS clinical trials. At Menter Dermatology Research Institute we are constantly adding new clinical trials to study HS. Check back often or sign up to receive an email regarding future HS clinical trials.
Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
Current HS Clinical Trial:
Clinical Trial Government Identifier #NCT03713619
Sponsor: Novartis
| Genders eligible for study: Male/Female | Ages eligible for study: 18 and older |
| NEW STUDY, NOW ENROLLING – HS (hidradenitis suppurativa) present for at least 1 year; at least 5 active lesions in two areas; no prior use of Cosentyx (secukinumab) allowed | August 2019 – TBD |
Please get in touch if you are interested in participating in the future, even if you do not see a trial that you currently qualify for!